Laveta Syrup contains Levocetirizine 2.5 mg per 5 ml, a second-generation antihistamine used primarily for the relief of allergic symptoms. Levocetirizine is an active enantiomer of cetirizine, exhibiting selective peripheral H1-receptor antagonism, which helps alleviate symptoms associated with allergic rhinitis, chronic urticaria, and other histamine-mediated conditions. This formulation is indicated for pediatric patients requiring effective management of nasal and ocular allergy symptoms such as sneezing, rhinorrhea, nasal congestion, itching, and watery eyes. Laveta Syrup offers a convenient oral liquid dosage form, facilitating accurate dosing and improved compliance in children. The medication is generally well tolerated, with a low incidence of sedation and anticholinergic side effects compared to first-generation antihistamines. It is recommended to administer Laveta Syrup once daily, with or without food, as directed by a healthcare professional. Caution is advised in patients with renal impairment, and dosage adjustments may be necessary. Contraindications include hypersensitivity to levocetirizine or any component of the formulation. Patients should be monitored for any adverse reactions, and use during pregnancy and lactation should be under medical supervision. Laveta Syrup represents an effective therapeutic option for managing allergic conditions in pediatric populations.